The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial-Reference-Cited by-同舟云学术

The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial

Published:2020-08-15 Issue:1 Volume:148 Page:150-160
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Roider Tobias¹²³^ORCID,Wang Xi¹²³,Hüttl Katrin⁴,Müller‐Tidow Carsten¹²³,Klapper Wolfram⁵,Rosenwald Andreas⁶,Stewart James Peter⁷,Castro David Gonzalez⁷,Dreger Peter¹,Hermine Olivier⁸,Kluin‐Nelemans Hanneke C.⁹,Grabe Niels¹⁰,Dreyling Martin¹¹,Pott Christiane¹²,Ott German⁴,Hoster Eva¹³,Dietrich Sascha¹²³

Affiliation:

1. Department of Medicine V, Hematology, Oncology and Rheumatology University of Heidelberg Heidelberg Germany

2. Molecular Medicine Partnership Unit (MMPU) Heidelberg Germany

3. European Molecular Biology Laboratory (EMBL) Heidelberg Germany

4. Department of Clinical Pathology Robert‐Bosch‐Hospital Stuttgart Germany

5. Department of Pathology University of Schleswig‐Holstein, Campus Kiel Kiel Germany

6. Institute of Pathology University of Würzburg Würzburg Germany

7. Centre for Cancer Research and Cell Biology Queen's University Belfast Belfast UK

8. Hôpital Necker‐Enfants Malades Paris France

9. Department of Hematology University Medical Centre Groningen, University of Groningen Groningen Netherlands

10. Hamamatsu Tissue Imaging and Analysis Center (TIGA), Bioquant University of Heidelberg Heidelberg Germany

11. Department of Medicine III University Hospital, Ludwig‐Maximilians‐Universität Munich Munich Germany

12. Second Medical Department University Hospital Schleswig‐Holstein, Campus Kiel Germany

13. Institute of Medical Informatics, Biometry and Epidemiology Ludwig‐Maximilians‐Universität Munich Munich Germany

Funder

Bundesministerium für Bildung und Forschung

Hairy Cell Leukemia Foundation

Robert Bosch Stiftung

Universität Heidelberg

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33202

Reference26 articles.

1. Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network

3. Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

4. Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

5. Treatment of Older Patients with Mantle-Cell Lymphoma

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the interplay between dNTP metabolism and genome stability in cancer;Disease Models & Mechanisms;2024-08-01

2. SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma;Blood;2024-05-09

3. Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1 via a comprehensive screening funnel;iScience;2024-02

4. SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer;Cellular Oncology;2023-09-04

5. Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1viaa comprehensive screening funnel;2023-01-18